PTPN1 and Obesity: Additional biochemical confirmation of PTP1B therapeutically targeting obesity and diabetes has been obtained from a diversity of sources, including overexpression in vitro, antisense oligonucleotide studies, mutation observation in the PTP1B human gene sequence and human single nucleotide polymorphisms [45].